English | EN 
Introduction
The “Holy Grail” of Medical AI is no longer just identifying a disease; it is determining exactly what to do about it. For years, we focused on Discriminative AI to flag abnormalities on a Chest X-ray. However, a diagnosis is only the beginning of a patient’s journey.
The integration of Multimodal Generative AI is now bridging the gap between radiology and therapeutics. By synthesizing the signal from imaging with the context of patient metadata, we are building systems capable of generating Personalized Treatment Protocols that are both clinically sound and intelligible to human specialists.
The Multimodal Input: Building the Patient’s Digital Context
To generate a treatment plan, the AI must go beyond the “pixels.” It requires a holistic understanding of the patient’s biological and clinical state.
- The Vision Layer: Deep learning backbones (like Vision Transformers) extract features from the Chest X-ray—detecting the size of a pleural effusion or the texture of a lung mass.
- The Metadata Layer: Structured data such as age, sex, smoking history, and chronic comorbidities (e.g., diabetes or hypertension) are encoded via specialized neural branches.
- The Clinical History Layer: Using Large Language Models (LLMs), the AI ingests unstructured notes from past consultations to understand the patient’s specific contraindications.
The Generative Engine: Synthesizing the “Treatment Script”
Unlike classical classifiers that output a risk score, Generative AI acts as a clinical synthesizer. Once the multimodal data is fused into a shared latent space, a generative decoder (similar to those used in GPT-4V or Med-PaLM) interprets the findings to draft a protocol.
Instead of a cryptic report, the AI generates a structured narrative:
“Given the patient’s age (72) and history of renal insufficiency, the pulmonary edema observed on the X-ray suggests a primary cardiac origin. Proposed Protocol: Initiate low-dose diuretics (Furosemide), monitor potassium levels daily, and schedule a follow-up echocardiogram within 48 hours.”
Bridging the Gap with “Explainable Prescription”
A major barrier to AI adoption in clinics is the “Black Box” nature of recommendations. Why this drug? Why this dose? Multimodal GenAI solves this through In-Context Learning. The system can explicitly cite the evidence used for the protocol:
- “I recommended a conservative dosage because the patient’s age and clinical history indicate a high risk of adverse reactions.”
- “The treatment choice is guided by the specific morphology of the infiltrates detected in the right upper lobe.”
Technical Challenges: Balancing Creativity and Safety
As researchers, our biggest hurdle is ensuring Medical Grounding. We cannot allow a generative model to “hallucinate” a dosage. We solve this by using Constrained Generation and Knowledge Graphs. We force the AI’s generative output to stay within the boundaries of established medical guidelines (like those from the WHO or ERS), ensuring that the “personalized” aspect never violates fundamental safety standards.
Conclusion: The AI as a Clinical Thought Partner
The shift from 2D image classification to multimodal treatment synthesis marks a new era of Augmented Medicine. By fusing signal processing, clinical metadata, and generative reasoning, we are creating tools that handle the data-heavy synthesis, allowing physicians to focus on the human-centric aspects of care. We aren’t just identifying the “what” anymore; we are empowering clinicians with the “how.”